Unicycive Therapeutics Files Definitive Proxy Statement
Ticker: UNCY · Form: DEF 14A · Filed: Apr 30, 2025 · CIK: 1766140
| Field | Detail |
|---|---|
| Company | Unicycive Therapeutics, Inc. (UNCY) |
| Form Type | DEF 14A |
| Filed Date | Apr 30, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, sec-filing
TL;DR
Unicycive's DEF 14A is out for the June 9th annual meeting. Get ready to vote.
AI Summary
Unicycive Therapeutics, Inc. filed its Definitive Proxy Statement (DEF 14A) on April 30, 2025, for its annual meeting scheduled for June 9, 2025. The filing provides information to shareholders regarding the meeting and related corporate matters. The company is based in Los Altos, California, and operates in the pharmaceutical preparations sector.
Why It Matters
This filing is crucial for shareholders as it outlines the agenda for the annual meeting, including any proposals to be voted on, and provides essential information for informed decision-making regarding the company's governance.
Risk Assessment
Risk Level: low — This filing is a standard procedural document for an annual shareholder meeting and does not inherently contain new financial risks.
Key Numbers
- 20250609 — Annual Meeting Date (Shareholders will vote on company matters on this date.)
- 20250430 — Filing Date (The proxy statement was officially filed with the SEC on this date.)
Key Players & Entities
- Unicycive Therapeutics, Inc. (company) — Registrant
- 20250609 (date) — Annual Meeting Date
- 20250430 (date) — Filing Date
- 4300 EL CAMINO REAL, SUITE 210 (address) — Company Headquarters
- LOS ALTOS, CA 94022 (address) — Company Headquarters
FAQ
What is the primary purpose of a DEF 14A filing?
A DEF 14A filing, or Definitive Proxy Statement, is used by companies to solicit proxies from shareholders for an upcoming annual or special meeting, providing detailed information about the matters to be voted upon.
When is the annual meeting of Unicycive Therapeutics, Inc. scheduled to take place?
The annual meeting of Unicycive Therapeutics, Inc. is scheduled for June 9, 2025.
Where is Unicycive Therapeutics, Inc. located?
Unicycive Therapeutics, Inc. is located at 4300 El Camino Real, Suite 210, Los Altos, CA 94022.
What is the SIC code for Unicycive Therapeutics, Inc.?
The Standard Industrial Classification (SIC) code for Unicycive Therapeutics, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
What is the filing date of this Definitive Proxy Statement?
This Definitive Proxy Statement was filed on April 30, 2025.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 30, 2025 regarding Unicycive Therapeutics, Inc. (UNCY).